LIB Therapeutics’ Post

View organization page for LIB Therapeutics

LIB Therapeutics

374 followers

11mo

Positive Results from Phase 3 LIBerate-HR (High Risk CVD) Study Announced at American College of Cardiology 2024 #lerodalcibep #PCSK9 #CVD #LDL https://lnkd.in/gWBX-6Qu

1 Comment

Summer XIA Shaofei, graphic

Summer XIA Shaofei

CEO | Board Member

10mo

Congrats!

To view or add a comment, sign in

LIB Therapeutics

374 followers

View Profile Follow

Explore topics

翻译：